Lotus Pharmaceutical Co., Ltd.

TWSE:1795.TW

271 (TWD) • At close September 19, 2024
Overview | Financials

Numbers are in millions (except for per share data and ratios) TWD.

202320222021202020192018201720162015201420132012201120102009
Assets:
Current Assets:
Cash & Cash Equivalents 1,770.881,983.3831,605.4951,489.0041,124.7191,023.2321,774.1722,015.4131,578.1811,095.5161,009.886190.884191.992469.684110.594
Short Term Investments 0-10.9130000025.35349.99474.15786.70350.61166.69602
Cash and Short Term Investments 1,770.881,983.3831,605.4951,489.0041,124.7191,023.2321,774.1722,040.7661,628.1751,169.6731,096.589241.495258.688469.684112.594
Net Receivables 6,617.244,927.4663,407.1982,800.6232,350.7361,213.8981,409.1361,377.4971,628.0322,474.307167.093139.663199.45183.643178.15
Inventory 3,775.383,329.8243,073.4042,208.491,323.6211,160.853923.357970.565904.3071,076.099179.388108.949109.3972.70486.563
Other Current Assets 489.373420.403247.238284.614671.09161.97199.81380.08496.414425.29630.8398.8112.1736.3516.944
Total Current Assets 12,652.87310,661.0768,333.3356,782.7315,470.1663,559.9544,206.4784,468.9124,256.9285,145.3751,473.909498.917579.701732.382384.251
Non-Current Assets:
Property, Plant & Equipment, Net 3,511.2173,148.2432,641.8372,305.4452,040.7861,814.9511,885.1411,954.2542,074.6861,992.796458.74505.083489.46343.391239.737
Goodwill 5,669.6215,667.6055,585.8475,895.6815,910.0266,083.4536,130.0326,008.9016,205.2496,180.27303.3490000
Intangible Assets 7,364.9957,315.3733,863.0343,830.992,897.152,185.1862,402.7841,880.1571,826.091,778.445235.4815.0786.4982.512.815
Goodwill and Intangible Assets 13,034.61612,982.9789,448.8819,726.6718,807.1768,268.6398,532.8167,889.0588,031.3397,958.7154.7815.0786.4982.512.815
Long Term Investments 3,216.7842,169.236301.728412.846458.0589.03510.517-5.244-30.133-60.667-77.48-32.803-37.295038.821
Tax Assets 411.687390.119310.816364.608378.647486.72449.168429.409527.772526.39833.11926.8249.0117.72529.707
Other Non-Current Assets 164.412174.421185.353161.117763.094714.384575.108507.744641.349707.467107.48181.96873.40844.6911.589
Total Non-Current Assets 20,338.71618,864.99712,888.61512,970.68712,447.76111,293.72911,452.7510,775.22111,245.01311,124.709526.641586.15541.081408.316322.669
Total Assets 32,991.58929,526.07321,221.9519,753.41817,917.92714,853.68315,659.22815,244.13315,501.94116,270.0842,000.551,085.0671,120.7821,140.698706.92
Liabilities & Equity:
Current Liabilities:
Account Payables 670.7961,403.042747.5471,731.724881.549727.571416.568467.518396.973430.26226.23825.86638.78541.76345.221
Short Term Debt 1,883.203274.8591,677.134450.431,093.805610881.1922,211.413442.062601.21111.71974.3899.77912.5748.889
Tax Payables 436.556731.151280.155226.61949.64776.576100.153202.06842.0047.1060.0650.1981.5184.2814.349
Deferred Revenue 132.854183.0841,880.3091,327891.97776.576-416.568-467.518793.3361,716.56674.06116.531125.98799.321102.266
Other Current Liabilities 1,837.4244,032.03320.9511,373.92791.782689.472997.2421,023.905130.961141.77811.475148.78317.1410.7718.468
Total Current Liabilities 4,524.2775,893.0184,325.9414,883.0812,959.1132,103.6191,878.4343,235.3181,763.3322,889.817123.492365.566491.692154.425204.844
Non-Current Liabilities:
Long Term Debt 9,519.3868,643.1094,710.4585,024.1373,838.8441,461.6044,411.3982,713.6974,111.9153,600.571355.9249.4150307.2918.75
Deferred Revenue Non-Current 45.32665.91585.957111.784104.038106.581,428.336681.205505.681516.7850.1140000
Deferred Tax Liabilities Non-Current 721.199448.397304.147144.688172.247197.211243.727252.487389.946424.9910.340000
Other Non-Current Liabilities 847.766607.744726.737844.3143,099.8563,303.9470.3120.4350.43526.98923.10532.80533.03932.03736.593
Total Non-Current Liabilities 11,133.6779,765.1655,827.2996,124.9237,214.9855,069.3426,083.7733,647.8245,007.9774,569.335389.47982.2233.039339.32845.343
Total Liabilities 15,657.95415,658.18310,153.2411,008.00410,174.0987,172.9617,962.2076,883.1426,771.3097,459.152512.971447.786524.731493.753250.187
Equity:
Preferred Stock 0000000283.3240022.3950000
Common Stock 2,649.5832,625.9132,627.9632,453.542,431.142,382.0072,384.9172,384.9172,384.9172,384.69743.922570.811445.811445.811362.231
Retained Earnings 8,900.0894,823.4171,700.635353.662-652.936-995.135-986.319-797.548-619.551-671.361-219.392-231.438-38.20415.07728.864
Accumulated Other Comprehensive Income/Loss 503.825287.555159.17659.266619.3331,087.1411,159.088-283.324177.5331.287-22.3950000
Other Total Stockholders Equity 5,280.1386,131.0056,580.9425,278.9465,344.4784,751.6824,728.3125,847.6935,860.2636,161.932963.049297.908188.444186.05765.638
Total Shareholders Equity 17,333.63513,867.8911,068.718,745.4147,742.0157,225.6957,285.9987,435.0627,803.1597,906.5481,487.579637.281596.051646.945456.733
Total Equity 17,333.63513,867.8911,068.718,745.4147,743.8297,680.7227,697.0218,360.9918,730.6328,810.9322,423.394637.281596.051646.945456.733
Total Liabilities & Shareholders Equity 32,991.58929,526.07321,221.9519,753.41817,917.92714,853.68315,659.22815,244.13315,501.94116,270.0842,000.551,085.0671,120.7821,140.698706.92